Soleno Therapeutics, Inc. (SLNO) Misses Q4 EPS by 6c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q4 EPS of ($0.33), $0.06 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• TSX miners rally as precious metals stocks dominate top gainers
• Yatsen Holding (YSG) Reports Q2 Loss of $0.16